I think you’ll find a few of us in here who have been around a while and have a thorough understanding of what the company is trying to achieve. From that understanding, some are quite confident that the upcoming Ph2B will yield statistically and clinically significant results.
But still: fingers crossed, and GLTAH.
- Forums
- ASX - By Stock
- DXB
- General Discussion
General Discussion, page-60
-
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
49.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $269.6M |
Open | High | Low | Value | Volume |
49.5¢ | 49.5¢ | 48.0¢ | $343.0K | 702.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 56500 | 48.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.0¢ | 1 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 73841 | 0.480 |
5 | 137807 | 0.475 |
8 | 215148 | 0.470 |
5 | 88930 | 0.465 |
7 | 131976 | 0.460 |
Price($) | Vol. | No. |
---|---|---|
0.490 | 51099 | 6 |
0.495 | 65592 | 7 |
0.500 | 152011 | 4 |
0.505 | 140396 | 3 |
0.510 | 90000 | 3 |
Last trade - 10.32am 15/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |